{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:22:44Z","timestamp":1793330564405,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170123"],"award-info":[{"award-number":["82170123"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00277-024-05633-y","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T16:02:16Z","timestamp":1706544136000},"page":"999-1005","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Low-dose venetoclax combined with azacitidine for blastic plasmacytoid dendritic cell neoplasm: a case report and literature review"],"prefix":"10.1007","volume":"103","author":[{"given":"Qiuyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinguang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"issue":"20","key":"5633_CR1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544","journal-title":"Blood"},{"issue":"4","key":"5633_CR2","doi-asserted-by":"publisher","first-page":"e23888","DOI":"10.7759\/cureus.23888","volume":"14","author":"D Molina Castro","year":"2022","unstructured":"Molina Castro D, Perilla Suarez O, Cuervo-Sierra J, Moreno A (2022) Blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report. Cureus 14(4):e23888. https:\/\/doi.org\/10.7759\/cureus.23888","journal-title":"Cureus"},{"issue":"2","key":"5633_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3324\/haematol.2012.072645","volume":"98","author":"L Pagano","year":"2013","unstructured":"Pagano L, Valentini CG, Pulsoni A, Fisogni S, Carluccio P, Mannelli F, Lunghi M, Pica G, Onida F, Cattaneo C, Piccaluga PP, Di Bona E, Todisco E, Musto P, Spadea A, D\u2019Arco A, Pileri S, Leone G, Amadori S, Facchetti F, Gimema A (2013) Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study. Haematologica 98(2):239\u2013246. https:\/\/doi.org\/10.3324\/haematol.2012.072645","journal-title":"Haematologica"},{"issue":"15","key":"5633_CR4","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1182\/blood.2021011817","volume":"138","author":"N Pemmaraju","year":"2021","unstructured":"Pemmaraju N, Wilson NR, Khoury JD, Jain N, Daver N, Pierce S, Jabbour E, Kadia T, DiNardo C, Garcia-Manero G, Qazilbash M, Konopleva M, Kantarjian H (2021) Central nervous system involvement in blastic plasmacytoid dendritic cell neoplasm. Blood 138(15):1373\u20131377. https:\/\/doi.org\/10.1182\/blood.2021011817","journal-title":"Blood"},{"issue":"1","key":"5633_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.prp.2010.05.008","volume":"207","author":"Y Li","year":"2011","unstructured":"Li Y, Li Z, Lin HL, Chen XH, Li B (2011) Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature. Pathol Res Pract 207(1):55\u201359. https:\/\/doi.org\/10.1016\/j.prp.2010.05.008","journal-title":"Pathol Res Pract"},{"issue":"6","key":"5633_CR6","first-page":"603","volume":"147","author":"A Pileri","year":"2012","unstructured":"Pileri A, Delfino C, Grandi V, Agostinelli C, Pileri SA, Pimpinelli N (2012) Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary. G Ital Dermatol Venereol 147(6):603\u2013608","journal-title":"G Ital Dermatol Venereol"},{"issue":"24","key":"5633_CR7","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1182\/bloodadvances.2019000647","volume":"3","author":"F Garnache-Ottou","year":"2019","unstructured":"Garnache-Ottou F, Vidal C, Biichle S, Renosi F, Poret E, Pagadoy M, Desmarets M, Roggy A, Seilles E, Soret L, Schillinger F, Puyraimond S, Petrella T, Preudhomme C, Roumier C, MacIntyre EA, Harrivel V, Desbrosses Y, Gruson B, Genevieve F, Thepot S, Drebit Y, Leguay T, Gros FX, Lechevalier N, Saussoy P, Salaun V, Cornet E, Benseddik Z, Veyrat-Masson R, Wagner-Ballon O, Salanoubat C, Maynadie M, Guy J, Caillot D, Jacob MC, Cahn JY, Gressin R, Rose J, Quesnel B, Guerin E, Trimoreau F, Feuillard J, Gourin MP, Plesa A, Baseggio L, Arnoux I, Vey N, Blaise D, Lacroix R, Arnoulet C, Benet B, Dorvaux V, Bret C, Drenou B, Debliquis A, Latger-Cannard V, Bonmati C, Bene MC, Peterlin P, Ticchioni M, Rohrlich PS, Arnaud A, Wickenhauser S, Bardet V, Brechignac S, Papoular B, Raggueneau V, Vargaftig J, Letestu R, Lusina D, Braun T, Foissaud V, Tamburini J, Bennani H, Freynet N, Cordonnier C, Le Garff-Tavernier M, Jacques N, Maloum K, Roos-Weil D, Bouscary D, Asnafi V, Lhermitte L, Suarez F, Lengline E, Feger F, Battipaglia G, Mohty M, Bouyer S, Ghoual O, Dindinaud E, Basle C, Puyade M, Lafon C, Fest T, Roussel M, Cahu X, Bera E, Daliphard S, Jardin F, Campos L, Solly F, Guyotat D, Galoisy AC, Eischen A, Mayeur-Rousse C, Guffroy B, Recher C, Loosveld M, Garnier A, Barlogis V, Rosenthal MA, Brun S, Contentin N, Maury S, Callanan M, Lefebvre C, Maillard N, Okamba P, Ferrand C, Adotevi O, Saas P, Angelot-Delettre F, Binda D, Deconinck E (2019) How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients? Blood Adv 3(24):4238\u20134251. https:\/\/doi.org\/10.1182\/bloodadvances.2019000647","journal-title":"Blood Adv"},{"key":"5633_CR8","doi-asserted-by":"publisher","unstructured":"Poussard M, Angelot-Delettre F, Deconinck E (2022) Conventional therapeutics in BPDCN patients-do they still have a place in the era of targeted therapies? Cancers (Basel) 14(15). https:\/\/doi.org\/10.3390\/cancers14153767","DOI":"10.3390\/cancers14153767"},{"issue":"1","key":"5633_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11864-019-0605-x","volume":"20","author":"D Kerr 2nd","year":"2019","unstructured":"Kerr D 2nd, Zhang L, Sokol L (2019) Blastic plasmacytoid dendritic cell neoplasm. Curr Treat Options Oncol 20(1):9. https:\/\/doi.org\/10.1007\/s11864-019-0605-x","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"5633_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/ajh.25000","volume":"93","author":"CD DiNardo","year":"2018","unstructured":"DiNardo CD, Rausch CR, Benton C, Kadia T, Jain N, Pemmaraju N, Daver N, Covert W, Marx KR, Mace M, Jabbour E, Cortes J, Garcia-Manero G, Ravandi F, Bhalla KN, Kantarjian H, Konopleva M (2018) Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies. Am J Hematol 93(3):401\u2013407. https:\/\/doi.org\/10.1002\/ajh.25000","journal-title":"Am J Hematol"},{"issue":"2","key":"5633_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1158\/2159-8290.CD-16-0999","volume":"7","author":"J Montero","year":"2017","unstructured":"Montero J, Stephansky J, Cai T, Griffin GK, Cabal-Hierro L, Togami K, Hogdal LJ, Galinsky I, Morgan EA, Aster JC, Davids MS, LeBoeuf NR, Stone RM, Konopleva M, Pemmaraju N, Letai A, Lane AA (2017) Blastic plasmacytoid dendritic cell neoplasm is dependent on BCL2 and sensitive to venetoclax. Cancer Discov 7(2):156\u2013164. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0999","journal-title":"Cancer Discov"},{"issue":"5","key":"5633_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.6004\/jnccn.2023.0025","volume":"21","author":"DA Pollyea","year":"2023","unstructured":"Pollyea DA, Altman JK, Assi R, Bixby D, Fathi AT, Foran JM, Gojo I, Hall AC, Jonas BA, Kishtagari A, Lancet J, Maness L, Mangan J, Mannis G, Marcucci G, Mims A, Moriarty K, Mustafa Ali M, Neff J, Nejati R, Olin R, Percival ME, Perl A, Przespolewski A, Rao D, Ravandi F, Shallis R, Shami PJ, Stein E, Stone RM, Sweet K, Thota S, Uy G, Vachhani P, Cassara CJ, Freedman-Cass DA, Stehman K (2023) Acute myeloid leukemia, version 3.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 21(5):503\u2013513. https:\/\/doi.org\/10.6004\/jnccn.2023.0025","journal-title":"J Natl Compr Canc Netw"},{"issue":"7","key":"5633_CR13","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, Chen W, Chen X, Chng WJ, Choi JK, Colmenero I, Coupland SE, Cross NCP, De Jong D, Elghetany MT, Takahashi E, Emile JF, Ferry J, Fogelstrand L, Fontenay M, Germing U, Gujral S, Haferlach T, Harrison C, Hodge JC, Hu S, Jansen JH, Kanagal-Shamanna R, Kantarjian HM, Kratz CP, Li XQ, Lim MS, Loeb K, Loghavi S, Marcogliese A, Meshinchi S, Michaels P, Naresh KN, Natkunam Y, Nejati R, Ott G, Padron E, Patel KP, Patkar N, Picarsic J, Platzbecker U, Roberts I, Schuh A, Sewell W, Siebert R, Tembhare P, Tyner J, Verstovsek S, Wang W, Wood B, Xiao W, Yeung C, Hochhaus A (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia 36(7):1703\u20131719. https:\/\/doi.org\/10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"issue":"1","key":"5633_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s13256-021-02939-7","volume":"15","author":"N Albiol","year":"2021","unstructured":"Albiol N, Novelli S, Mozos A, Pratcorona M, Martino R, Sierra J (2021) Venetoclax in relapsed\/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature. J Med Case Rep 15(1):326. https:\/\/doi.org\/10.1186\/s13256-021-02939-7","journal-title":"J Med Case Rep"},{"issue":"3","key":"5633_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ajh.24258","volume":"91","author":"U Deotare","year":"2016","unstructured":"Deotare U, Yee KW, Le LW, Porwit A, Tierens A, Musani R, Barth D, Torlakovic E, Schimmer A, Schuh AC, Seftel M, Minden MD, Gupta V, Hyjek E (2016) Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-color flow cytometry diagnosis and HyperCVAD therapy. Am J Hematol 91(3):283\u2013286. https:\/\/doi.org\/10.1002\/ajh.24258","journal-title":"Am J Hematol"},{"issue":"11","key":"5633_CR16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.clml.2021.05.018","volume":"21","author":"NR Wilson","year":"2021","unstructured":"Wilson NR, Konopleva M, Khoury JD, Pemmaraju N (2021) Novel Therapeutic approaches in blastic plasmacytoid dendritic cell neoplasm (BPDCN): era of targeted therapy. Clin Lymphoma Myeloma Leuk 21(11):734\u2013740. https:\/\/doi.org\/10.1016\/j.clml.2021.05.018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"10","key":"5633_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1080\/17512433.2019.1662297","volume":"12","author":"MP Economides","year":"2019","unstructured":"Economides MP, McCue D, Lane AA, Pemmaraju N (2019) Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm. Expert Rev Clin Pharmacol 12(10):941\u2013946. https:\/\/doi.org\/10.1080\/17512433.2019.1662297","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"5633_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.hoc.2020.01.007","volume":"34","author":"AA Lane","year":"2020","unstructured":"Lane AA (2020) Novel therapies for blastic plasmacytoid dendritic cell neoplasm. Hematol Oncol Clin North Am 34(3):589\u2013600. https:\/\/doi.org\/10.1016\/j.hoc.2020.01.007","journal-title":"Hematol Oncol Clin North Am"},{"issue":"17","key":"5633_CR19","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1182\/blood.2019002841","volume":"135","author":"WG Wierda","year":"2020","unstructured":"Wierda WG, Tambaro FP (2020) How I manage CLL with venetoclax-based treatments. Blood 135(17):1421\u20131427. https:\/\/doi.org\/10.1182\/blood.2019002841","journal-title":"Blood"},{"issue":"24","key":"5633_CR20","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1182\/bloodadvances.2019000937","volume":"3","author":"DA Pollyea","year":"2019","unstructured":"Pollyea DA, Amaya M, Strati P, Konopleva MY (2019) Venetoclax for AML: changing the treatment paradigm. Blood Adv 3(24):4326\u20134335. https:\/\/doi.org\/10.1182\/bloodadvances.2019000937","journal-title":"Blood Adv"},{"issue":"7","key":"5633_CR21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1056\/NEJMc1814963","volume":"380","author":"N Pemmaraju","year":"2019","unstructured":"Pemmaraju N, Konopleva M, Lane AA (2019) More on blastic plasmacytoid dendritic-cell neoplasms. N Engl J Med 380(7):695\u2013696. https:\/\/doi.org\/10.1056\/NEJMc1814963","journal-title":"N Engl J Med"},{"issue":"3","key":"5633_CR22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/bjd.12412","volume":"169","author":"F Julia","year":"2013","unstructured":"Julia F, Petrella T, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P, Dereure O, Wetterwald M, d\u2019Incan M, Grange F, Cornillon J, Tertian G, Maubec E, Saiag P, Barete S, Templier I, Aubin F, Dalle S (2013) Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol 169(3):579\u2013586. https:\/\/doi.org\/10.1111\/bjd.12412","journal-title":"Br J Dermatol"},{"issue":"3","key":"5633_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.hoc.2020.01.010","volume":"34","author":"E Deconinck","year":"2020","unstructured":"Deconinck E, Petrella T, GarnacheOttou F (2020) Blastic plasmacytoid dendritic cell neoplasm: clinical presentation and diagnosis. Hematol Oncol Clin North Am 34(3):491\u2013500. https:\/\/doi.org\/10.1016\/j.hoc.2020.01.010","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05633-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05633-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05633-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T10:06:56Z","timestamp":1707905216000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05633-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["5633"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05633-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]},"assertion":[{"value":"10 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the ethics committees of Qilu Hospital of Shandong University according to the Helsinki Principles. Written informed consent was obtained from the patient for the publication of the clinical information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}